InvestorLens

BIO — BIO-RAD LABORATORIES INC - US

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BIO?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Net accumulation · 3 buying vs 0 selling last quarter
67
Macro Tailwind
Macro conditions are mixed for this sector
56
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their BIO position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Expansion regime).

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin, Paul Tudor Jones)
  • +3 tracked investors reported holding BIO at their latest filing
  • +Macro Health is 56/100 in a Expansion regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/19/2026.

About BIO-RAD LABORATORIES INC - US (BIO)

BIO-RAD LABORATORIES INC - US (BIO) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $197M. Across recent filings, tracked investors recorded 8 new positions, 4 increased, 5 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BIO

55
/100
Mixed Activity
Added / Increased12
Reduced5
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track BIO

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BIO Ownership Composition

How BIO-RAD LABORATORIES INC - US is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
83% of tracked value
Institutions
3
tracked investors
Total Reported
$43.7M
combined 13F value
Types2
  • Multi-Strategy / Quant83.2%
  • Macro16.8%
Multi-Strategy / Quant(2)
83.2%
Macro(1)
16.8%

Tracked investors currently reporting BIO

2 tracked investors have since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    59.9K
    Value
    $17.6M
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    63.9K
    Value
    $18.8M
    % Portfolio
    0.00%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    25K
    Value
    $7.3M
    % Portfolio
    0.01%

Previously held BIO

These investors reported BIO in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management250.1K$83.7MSep 30, 2024
Ray DalioBridgewater Associates771$248.9KDec 31, 2023

Recent activity

Frequently asked questions

How many institutional investors hold BIO?
3 tracked institutional investors disclosed a position in BIO (BIO-RAD LABORATORIES INC - US) in their most recent 13F filing.
Who is the largest institutional holder of BIO?
Izzy Englander, Millennium Management, holds the largest disclosed position in BIO, valued at $197M.
Did institutional ownership of BIO increase or decrease?
Across recent 13F filings, tracked investors recorded 8 new positions, 4 increased, 5 reduced, and 5 fully exited BIO.
Where does this BIO ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.